Moreover, expression of DROSHA has been recently shown to be impaired in breast cancer patients, possibly in the attempt to stimulate HR, although the molecular mechanisms by which this may be relevant for cancer development remain to be defined (Poursadegh Zonouzi et al., 2017). Here, DROSHA is linked to breast cancer.